Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
10-Dec-14 Mergers and acquisitions in China’s healthcare sector rose to a record USD11.3 billion in the first 11 months of 2014, up 13% from a year earlier. A combination of ageing population and increasing affluence is driving the deal-making, coinciding with sweeping reforms by Chinese government. [image: Feucht Blog]
For more about China's healthcare sector, download our free 20-page whitepaper: China healthcare market opportunitiesRead More
10-Dec-14 The Mexican Health Ministry has taken an important step to ensure access to palliative care for people suffering from pain due to incurable illness, releasing long-awaited guidelines that will put into practice the provisions on end-of-life care outlined in the country’s 2009 health law. Seven of Mexico’s 32 states have no hospitals offering palliative care. [image: Human Rights Watch]Read More
09-Dec-14 Increasing numbers of hospitals in Vietnam are being equipped with modern technology and German companies are at the forefront: Siemens has been providing imaging and laboratory diagnostics since 1993, B. Braun is raising its investment in Vietnam to USD270 million, and other German firms doing well in Vietnam include Boehringer Ingelheim, Draeger, Rudolf Lietz, Fresenius Kabi, Bayer Schering and Merck. [image: Vietnam Investment Review]Read More
05-Dec-14 India produces a third of the world's medicines, mostly in the form of generic drugs. But more than 80% of the raw materials for these drugs are imported from China. That gives its neighbour a virtual monopoly over pricing and supply - so much so that there are now no domestic Indian producers of many essential medicines, a situation that worries the Indian government. [image: The Insider]Read More
04-Dec-14 GE Healthcare Life Sciences is planning to open a Technology Laboratory in Turkey which will feature the company’s latest tools for drug discovery, protein science and bioprocessing research. Turkey plans to transform its domestic manufacturing of devices and pharmaceuticals, with plans for 60% of demand to be met locally. [image: GE Healthcare Life Sciences]Read More
GGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Enter your work email to receive our free GROW newsletter on international market intelligence and strategy.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Get in touch to discuss your growth markets research and advisory needs: